Women's Health Exam 1

Front 1

Which of the following statements are true regarding STDs?
a. In developing countries, women of childbearing age, STDs (excluding HIV) is the top cause of disease, death and healthy life lost.
b. In women ages 15-24, 1 in 2 have had an STI
c. Men are 5 more times likely than women to get an STI
d. Risk factors for women include increased exposure and anatomical attachment
e. According to studies between 1-10% of women have been assaulted at one point in their lifetime

Back 1

d. Risk factors for women include increased exposure and anatomical attachment

a. second only to maternal factors
b. 1 in 4
c. Women are 5 times more likely
e. 10-69%

Front 2

Adolescents have increased sexual health infection risk due to
a. Squamous epithelium extending into ectocervix
b. Columnar epithelium extending into ectocervix
c. Thinner cervical mucous
d. Thicker cervical mucous
e. Higher estrogen in early adolescents
f. Lower estrogen in early adolescents
g. a, d and e
h. b, c and f

Back 2

h. b, c and f

b. Columnar epithelium extending into ectocervix
c. Thinner cervical mucous
f. Lower estrogen in early adolescents

Front 3

Which of the following is true about douching?
a. Decreased risk of STIs
b. Increased elimination of peroxidase producing lactobacilli
c. Decreased ectopic pregnancy
d. Decreased Pelvic inflammatory disease
e. Increased protection against other pathogens

Back 3

b. Increased elimination of peroxidase producing lactobacilli

Front 4

Bacterial vaginosis includes:
a. Disruption in the normal flora
b. High concentration of aerobic bacteria
c. Reduced risk of premature rupture of membranes in
pregnancy
d. Discharge pH <4-5
e. Cottage cheese vaginal discharge

Back 4

a. Disruption in the normal flora

b. anaerobic
c. Greater
d. >4-5
e. Fishy odor discharge

Front 5

First line treatment for bacterial vaginosis is:
a. Metronidazole 500mg po BID x 7 days
b. Metronidazole gel 0.75% intravaginally daily x 5 days
c. Clindamycin 2% cream intravaginally qhs x 7 days
d. Metronidazole 500mg po BID x 7 days in pregnant women
e. Clindamycin 300mg po BID x 7 days in pregnant women
f. All of the above

Back 5

f. All of the above

Front 6

The most common pathogen in vulvovaginal candidiasis (VVC) is
a. Candida glabrata
b. lactobacilli
c. Candida albicans
e. Staph aureus
f. Strep pneumoniae

Back 6

c. Candida albicans

Front 7

Risk factors for vulvovaginal candidiasis include
a. Taking probiotics
b. Developing immune system
c. Decreased estrogen
d. Uncontrolled DM
e. Not being pregnant

Back 7

d. Uncontrolled DM

a. antibiotics
b. Immunocompromised (HIV, steroids)
c. Elevated estrogen (pregnancy, mentral cycle, OCs)
e. Being pregnant

Front 8

Gonorrhea first-line treatment includes
a. Uncomplicated infection of cervix, urethra & rectum or pharynx: Ceftriaxone 125mg IM ‐single dose
b. Disseminated infection: Cefoxitin 2g IM w/probenecid 1g POsingle dose
c. Disseminated infection: Cefotaxime 500mg IM ‐single dose
d. Uncomplicated infection of pharynx: Cefotaxime 500mg IM ‐single dose
e. Uncomplicated infection of cervix, urethra & rectum: Cefotaxime 500mg IM ‐single dose

Back 8

a. Uncomplicated infection of cervix, urethra & rectum or pharynx: Ceftriaxone 125mg IM ‐single dose

Front 9

Chlamydia trachomatis preferred treatment includes:
a. Levofloxacin 500mg daily
b. Azithromycin 1 gram orally single dose
c. Erythromycin succinate 800mg QID
d. Doxycycline 100mg po BID x 7days
e. Ofloxacin 300mg BID
f. B or D
g. A or C

Back 9

f. B or D

Front 10

Which of the following drugs are CI in pregnancy for chlamydia trachomatis:
a. Azithromycin 1 gram orally single dose
b. Amoxicillin 500mg orally TID for 7 days
c. Doxycycline 100mg po BID x 7days
d. Levofloxacin 500mg daily
e. C and D

Back 10

e. C and D

Front 11

Symptoms of Trichomonas in women include
a. Dysurea
b. strawberry vulva or cervix
c. Vulvovaginal soreness
d. Frothy white or green foul smelling discharge
e. All of the above

Back 11

e. All of the above

Front 12

Unacceptable treatments for Trichomonas include
a. Metronidazole 2 grams orally as a single dose
b. Metronidazole 500mg po BID x 7 days in first trimester
b. Metronidazole 500mg po BID x 7 days in third trimester
c. Tinidazole 2 grams orally if metronidazole resistance
d. None of the above

Back 12

b. Metronidazole 500mg po BID x 7 days in third trimester

Front 13

A patient presents with a Painless, singular lesion, Bilateral, Nontender Lymphadenopathy and no systemic infection

What infection is this most likely
a. Genital herpes
b. Primary Syphilis
c. Trichomonas
d. Chlamydia trachomatis
e. Gonorrhea

Back 13

b. Primary Syphilis

Front 14

Treatment options for Primary Syphilis include
a. Benzathine penicillin G 2.4 million units IM in a single dose for Latent Syphilis
b. Doxycycline 100 mg orally twice daily for 28 days for Penicillin-Allergic Secondary Syphilis
c. Benzathine penicillin G 2.4 million units IM in a single dose for Early Latent Syphilis
d. Benzathine penicillin G
3 doses of 2.4 million units IM each at 1‐week intervals for Early Latent Syphilis
d. Aqueous crystalline penicillin G 3‐4 million units IV
q4 hrs for 10‐14 days for Syphilis of Unknown Duration

Back 14

c. Benzathine penicillin G 2.4 million units IM in a single dose for Early Latent Syphillis

Front 15

Treatment for Jarisch‐Herxheimer Reaction includes
a. Penicillin
b. bed rest and NSAIDS
c. Cephalosporins
d. Benzocaine
e. Doxycycline

Back 15

b. bed rest and NSAIDS

Front 16

Appropriate regiments for HSV/Non‐HIV Infected Patient include
a. Acyclovir 400mg BID continuously for New Episode
b. Acyclovir 800mg BID for recurrent (5 days)
c. Famciclovir 250mg TID for recurrent infections (5 days)
d. Famciclovir 250mg BID for new episodes (7‐10 days)
e. Valacyclovir 500mg BID for 3‐5 days for suppression

Back 16

b. Acyclovir 800mg BID for recurrent (5 days)

a. TID for 7‐10 days
c. 125 mg BID
d. TID
e. Continuously

Front 17

Recommended drug therapy for HIV Postexposure Prophylaxis
a. Combivir (AZT/lamivudine) or Truvada (tenofovir & emtricitabine)
b. Add efavirenz (if pregnant)
c. Kaletra (lopinavir/ritonavir BID) if non-pregnant
d. No other boosted PIs
e. Vaginal Tenofovir 1% Gel if applied gel intravaginally only after sex

Back 17

a. Combivir (AZT/lamivudine) or Truvada (tenofovir & emtricitabine)

b. non-pregnant
c. if pregnant
d. Boosted PIs are also an option
e. prior to and after sex

Front 18

Pelvic Inflammatory Disease treatment for 14 days includes:
a. Cefotetan 2g q IV 12hrs or cefoxitin 2g IV q6hrs
b. Cefotetan 2g q IV 12hrs or cefoxitin 2g IV q6hrs Plus doxycycline 100mg BID po or IV q 12hrs
c. Doxycycline 100mg BID po or IV q 12hrs
d. Ceftriaxone 250mg IM alone
e. Metronidazole 500mg po BID

Back 18

b. Cefotetan 2g q IV 12hrs or cefoxitin 2g IV q6hrs Plus doxycycline 100mg BID po or IV q 12hrs